Biotech News 27 Nov 2024 Innovating LNP design to improve mRNA therapeutics The new approach involving refinement and optimisation of ionisable lipids could accelerate the development of mRNA therapies, research suggests. A… Pantitra
Biotech News 19 Nov 2024 Whooping cough vaccine urged for children The Ministry of Public Health is encouraging people, especially children and those in physical contact with them, to get vaccinated… Pantitra
Biotech News 28 Oct 2024 Novel mRNA vaccine prevents and treat C. difficile Penn Medicine and the Children’s Hospital of Philadelphia have developed the first mRNA vaccine against C. difficile to successfully ward… Pantitra
Biotech News 23 Oct 2024 Is mRNA vaccine, the next immunotherapy frontier? Utilising mRNA’s versatility to elicit potent immune responses against cancer, these vaccines can prompt the immune system to recognise and… Pantitra
Biotech News 18 Oct 2024 mRNA vaccines for disease outbreaks can be synthesized in less time with new technique The phosphorylation reagent with a nitrobenzyl hydrophobic tag allows production of high purity fully chemically synthesized mRNA and transcriptionally synthesized… Pantitra
Biotech News 27 Sep 2024 Machine learning powers discovery of new molecules to enhance the safe freezing of medicines and vaccines Scientists from The University of Manchester and the University of Warwick have developed a cutting-edge computational framework that enhances the… Pantitra
Biotech News 25 Sep 2024 A two-dose schedule could make HIV vaccines more effective MIT researchers find that the first dose primes the immune system, helping it to generate a strong response to the… Pantitra
Biotech News 23 Sep 2024 Differentiating Between DNA and mRNA Platforms Ami Patel, PhD, provides insights on both technologies and how her research center, the Wistar Institute, is involved in DNA… Pantitra
Biotech News 21 Sep 2024 Into the unknown: How quickly can vaccines be developed for Disease R&D frameworks are in place for the next pandemic-causing pathogen, but ways to derisk development are unclear. ‘Disease X’ is… Pantitra
Biotech News 19 Sep 2024 A new way to reprogram immune cells and direct them toward anti-tumor immunity MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine. In new research… Pantitra
